Health Care Roundup: Market Talk

Dow Jones
Yesterday

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

0318 GMT - Top Glove's earnings have likely peaked and could trend lower toward normalized levels in the coming quarters, says CIMB Securities analyst Chun Sung Oong in a note. While glove prices could remain elevated, they have already eased from their June peak, he reckons. Higher labor costs and a 39% increase in natural gas tariffs could also weigh on earnings. Oong raises Top Glove FY2027-FY2028 core net profit estimates by 1%-19%, after its FY2026 earnings beat estimates. CIMB raises Top Glove's target price to 0.70 ringgit from 0.63 ringgit, but keeps a reduce rating, citing an unfavorable industry outlook amid persistent global oversupply and intense competition from Chinese manufacturers. Shares are 1.7% higher at 0.89 ringgit. (yingxian.wong@wsj.com)

0116 GMT - Top Glove could post sequentially weaker fiscal 1Q earnings, as pricing power fades, natural gas costs rise, and tax benefits diminish, says Hong Leong IB analyst Chee Kok Siang in a note. Average selling prices are expected to decline from 4Q FY2026 levels, which were boosted by delayed shipments carrying higher May prices. Price increases in October and November may provide some support, but are unlikely to drive margins as strongly as in recent quarters amid a more balanced supply of nitrile rubber, he reckons. Chee raises Top Glove's FY2027-FY2028 earnings estimates by 4.1%-52.8% after its FY2026 earnings beat and raises the target price to 0.73 ringgit from 0.68 ringgit. However, Chee downgrades the stock's rating to sell from hold given concerns over structural oversupply. Shares are 5.7% higher at 0.93 ringgit. (yingxian.wong@wsj.com)

0105 GMT - Top Glove's improved earnings prospects are likely more than reflected in its share price following the recent rally, despite a more positive outlook for average selling prices, Maybank IB analyst Wong Wei Sum says in a note. Management guided higher average selling prices trend for October and November as Chinese glove makers show greater discipline and demand and supply become more balanced, she notes. Cost efficiencies should also support sustainable pretax margins of around 8%-12%, she says. However, potential minimum-wage increases could raise production costs. Wong raises Top Glove's FY2027-FY2028 earnings estimates by 113%-116%, as FY2026 earnings beat expectations. Maybank raises Top Glove's target price to 0.73 ringgit from 0.71 ringgit, while maintaining a sell rating. Shares are 2.3% higher at 0.90 ringgit.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10